US2006229319A1PendingUtilityA1

Enantiomers of 1-[(4-chlorophenyl) phenylmethyl)-4-[(4-methylphenyl)sulfonyl] piperazine

64
Assignee: COSSEMENT ERICPriority: Mar 5, 1993Filed: Jun 16, 2006Published: Oct 12, 2006
Est. expiryMar 5, 2013(expired)· nominal 20-yr term from priority
Inventors:Eric CossementGuy BodsonJean Gobert
A61P 37/08A61P 43/00A61P 29/00A61P 25/20A61P 25/22A61P 17/00C07D 295/26A61P 11/06C07D 295/073C07D 295/088A61K 31/495
64
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method is disclosed for the treatment of an allergic condition associated with a cutaneous reaction induced by histamine. There is administered to a patient in need of such treatment the levorotatory dihydrochloride of 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy] acetic acid.

Claims

exact text as granted — not AI-modified
1 - 8 . (canceled)  
     
     
         9 . A method for the treatment of an allergic condition associated with a cutaneous reaction induced by histamine which comprises administering to a patient in need of such treatment an effective amount of the substantially pure levorotatory dihydrochloride of 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy] acetic acid.

Join the waitlist — get patent alerts

Track US2006229319A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.